CircPTK2/PABPC1/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer
Cancer Letters · 2023-02 · 554 · 216023
DOI: 10.1016/j.canlet.2022.216023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2023-02. Verfasst von Xiangui Meng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Shenzhen Huazhong…. Hauptthemen laut MEDLINE: MicroRNAs, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 114-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Bladder cancer (BCa), characterized by high invasion, metastasis, recurrence, and chemoresistance, is one of the most prevalent urologic malignant tumors. Recent studies have highlighted the potential impact of the circRNAs-protein complex in tumorigenesis. However, the mechanisms by which the circRNAs-protein complex regulates BCa metastasis and chemoresistance remain elusive. Herein, we identified an upregulated circRNA, circPTK2, which could regulate SETDB1 expression by analyzing the transcriptome by RNA-sequencing. Importantly, using circRNA pulldown assay and RNA-binding protein immunoprecipitation, we identified PABPC1 as a robust novel interacting protein of circPTK2. Mechanistically, circPTK2 could bind to PABPC1 and enhance its ability to stabilize SETDB1 mRNA, thereby specifically promoting SETDB1 expression and facilitating SETDB1-mediated epithelial-mesenchymal transition (EMT). Functionally, overexpression of the circPTK2-SETDB1 axis markedly promoted migration, invasion, and gemcitabine resistance in vitro and enhanced lymph node metastasis in vivo. Collectively, our findings clarified a hitherto unexplored mechanism of the circPTK2/PABPC1/SETDB1 axis in EMT-mediated tumor metastasis and gemcitabine resistance in BCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Shenzhen Huazhong University of Science and Technology Research Institute, Shenzhen, 51…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Meng, X., Xiao, W., Sun, J., Li, W., Yuan, H., Yu, T., Zhang, X., & Dong, W. (2023). CircPTK2/PABPC1/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer. Cancer Letters, 554, 216023. https://doi.org/10.1016/j.canlet.2022.216023
Vancouver
Meng X, Xiao W, Sun J, Li W, Yuan H, Yu T, et al. CircPTK2/PABPC1/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer. Cancer Letters. 2023;554:216023. doi:10.1016/j.canlet.2022.216023
BibTeX
@article{Meng2023,
author = {Meng, Xiangui and Xiao, Wen and Sun, Jiayin and Li, Weiquan and Yuan, Hongwei and Yu, Tiexi and Zhang, Xiaoping and Dong, Wei},
title = {CircPTK2/PABPC1/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer},
journal = {Cancer Letters},
year = {2023},
volume = {554},
pages = {216023},
doi = {10.1016/j.canlet.2022.216023}
}
EUVIMED